Charles River Laboratories International CRL
NYSE CRL
$304.40 +5.38 (+1.80%)
As of: Oct 14, 2026 · 2:08 PM EDT

Charles River Laboratories International (CRL) Capital Expenditures (2009 - 2026)

Updated

Charles River Laboratories International (CRL) posted Capital Expenditures of $31.11 million for Q2 2026, down 11.9% from $35.3 million a year earlier and down 44.4% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Capital Expenditures (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 27, 2026, Capital Expenditures at Charles River Laboratories International was $211.54 million, up 1.2% year-over-year; for FY2025, it came in at $219.15 million, down 5.9% from FY2024.

  • Annual Capital Expenditures has declined for three consecutive years, though with a five-year compound annual growth rate of 5.6% (FY2020 to FY2025).
  • In prior years, Charles River Laboratories International's Capital Expenditures was $232.97 million in FY2024 (-26.9%), $318.53 million in FY2023 (-1.9%), $324.73 million in FY2022 (+41.9%) and $228.77 million in FY2021 (+37.4%).
  • The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q1 2021.
  • On a year-over-year basis, Capital Expenditures increased in 1 of the last eight quarters, with an average decline of 11.1%.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2022, with growth of 187.1%; the weakest was Q2 2024, with a decline of 41.4%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $55.91 million (Q1 2026), $88.95 million (Q4 2025) and $35.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Iqvia Holdings 43.61 Bn 35.31 Bn 1.44 Bn 198.00 Mn
2 Medpace Holdings 17.34 Bn 15.40 Bn 201.64 Mn 23.91 Mn
3 Charles River Laboratories International 14.63 Bn 13.82 Bn 363.37 Mn 31.11 Mn
4 Icon 13.16 Bn 10.27 Bn 479.29 Mn 42.42 Mn
5 Fortrea Holdings 2.02 Bn 1.40 Bn 139.20 Mn 9.00 Mn
6 Ginkgo Bioworks Holdings 723.40 Mn -38.68 Mn 18.44 Mn 2.62 Mn
7 Evotec SE 502.55 Mn -1.11 Bn - -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn 55,000.00
9 MindWalk Holdings 63.08 Mn 26.73 Mn 1.61 Mn 55,941.69
10 Natural Alternatives International 6.81 Mn -21.27 Mn 1.73 Mn 637,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 31.11 Mn
Mar 28, 2026 55.91 Mn
Dec 27, 2025 88.95 Mn
Sep 27, 2025 35.58 Mn
Jun 28, 2025 35.30 Mn
Mar 29, 2025 59.32 Mn
Dec 28, 2024 75.62 Mn
Sep 28, 2024 38.72 Mn
Jun 29, 2024 39.49 Mn
Mar 30, 2024 79.14 Mn
Dec 30, 2023 78.32 Mn
Sep 30, 2023 65.95 Mn
Jul 1, 2023 67.38 Mn
Apr 1, 2023 106.88 Mn
Dec 31, 2022 89.02 Mn
Sep 24, 2022 72.39 Mn
Jun 25, 2022 82.85 Mn
Mar 26, 2022 80.46 Mn
Dec 25, 2021 98.78 Mn
Sep 25, 2021 55.54 Mn
API Access

Charles River Laboratories International Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRL&period=max&api_key=YOUR_API_KEY